Cargando…

Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) has a bidirectional association with metabolic syndrome. It affects up to 30% of the general population, 70% of individuals with diabetes and 90% with obesity. The main histological hallmark of progressive NAFLD is fibrosis. There is a b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alazawi, William, Bernabe, Eduardo, Tai, David, Janicki, Tomasz, Kemos, Polychronis, Samsuddin, Salma, Syn, Wing-Kin, Gillam, David, Turner, Wendy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722374/ https://www.ncbi.nlm.nih.gov/pubmed/29220367 http://dx.doi.org/10.1371/journal.pone.0185902

Ejemplares similares

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease
por: Hou, Wei, et al.
Publicado: (2020)

Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
por: Waller, Kathryn Jane, et al.
Publicado: (2023)

The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome
por: Lu, Zhongyang, et al.
Publicado: (2023)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

The contribution of daytime sleepiness to impaired quality of life in NAFLD in an ethnically diverse population
por: Li, Wenhao, et al.
Publicado: (2022)

A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease
por: Manka, Paul P., et al.
Publicado: (2021)

Patient perspectives of artificial intelligence as a medical device in a skin cancer pathway
por: Kawsar, Anusuya, et al.
Publicado: (2023)

Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
por: Mazzolini, Guillermo, et al.
Publicado: (2020)

Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Glass, Oliver, et al.
Publicado: (2018)

Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis
por: Hou, Wei, et al.
Publicado: (2018)

NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease
por: Manka, Paul, et al.
Publicado: (2020)

VEGF-A and ICAM-1 Gene Polymorphisms as Predictors of Clinical Outcome to First-Line Bevacizumab-Based Treatment in Metastatic Colorectal Cancer
por: Papachristos, Apostolos, et al.
Publicado: (2019)

Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease
por: Hernández-Conde, Marta, et al.
Publicado: (2020)

Effectiveness of an image analyzing AI-based Digital Health Technology to identify Non-Melanoma Skin Cancer and other skin lesions: results of the DERM-003 study
por: Marsden, Helen, et al.
Publicado: (2023)

The significance of ovarian fibrosis
por: Landry, David A., et al.
Publicado: (2020)

High Meat Consumption Is Prospectively Associated with the Risk of Non-Alcoholic Fatty Liver Disease and Presumed Significant Fibrosis
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2022)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients
por: Araki, Norimasa, et al.
Publicado: (2020)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry
por: Aardoom, Martine A, et al.
Publicado: (2021)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Significance of maternal periodontal health in preeclampsia
por: Desai, Khushboo, et al.
Publicado: (2015)

Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It
por: Yen, Pei-Chia, et al.
Publicado: (2022)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Oral Hygiene and Periodontal Treatment Needs in Adult Patients with Cystic Fibrosis (CF)
por: Hildebrandt, Tomasz, et al.
Publicado: (2022)

Molecular dynamics simulation of Fe-NO(2) At-alpha mangostin as radiopharmaceutical model for detection of fatty acid synthase in cancer
por: Rosilawati, N. Elly, et al.
Publicado: (2021)

Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2021)

Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD
por: Blomdahl, Julia, et al.
Publicado: (2023)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022)

An overview of periodontal regenerative procedures for the general dental practitioner
por: Siaili, M., et al.
Publicado: (2018)

The role of periodontal niches in influencing the tongue microbiota: relationship with periodontitis and oral malodour
por: Stephen, A. S., et al.
Publicado: (2017)

Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
por: Kozłowska-Petriczko, Katarzyna, et al.
Publicado: (2021)

Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD
por: Romano, John, et al.
Publicado: (2022)

Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
por: Alexander, Myriam, et al.
Publicado: (2018)

Prevalence of Moderate to Severe Periodontitis in an 18–19th Century Sample—St. Bride’s Lower Churchyard (London, UK)
por: Al-Mutairi, Ruqayah, et al.
Publicado: (2022)

Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome
por: Kositamongkol, Chayanis, et al.
Publicado: (2021)

Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
por: Dai, Yi-Ning, et al.
Publicado: (2023)

The Prevalence of Root Sensitivity following Periodontal Therapy: A Systematic Review
por: Lin, Y. H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_koqbpvssbm99ejph8pv6ghggre